NEARVUE
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Oct 2022)
What this means for you
This application is over — abandoned 24 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90576817
- Mark type
- Stylized text
- Filed
- 12 Mar 2021
- Published for opposition
- 27 Jul 2021
- Abandoned
- 24 Oct 2022
- Attorney of record
- Matthew E. Moersfelder
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmic drugs
Owner
- Visus Therapeutics Inc., Seattle, WA, US
- Visus Therapeutics Inc., Seattle, WA, US
Prosecution history
- 24 Oct 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Oct 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2022 — SOU EXTENSION 1 GRANTED
- 04 Mar 2022 — SOU EXTENSION 1 FILED
- 04 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Oct 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Oct 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 21 Sept 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Jul 2021 — PUBLISHED FOR OPPOSITION
- 07 Jul 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Jun 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jun 2021 — ASSIGNED TO EXAMINER